Clinisupplies Acquires Great Bear Healthcare to Expand Direct-to-patient Chronic Care Services in the Community
Clinisupplies, a leading manufacturer and supplier of continence care consumables, today announced the acquisition of Great Bear Healthcare, a UK-based manufacturer and supplier of continence products for managing acute and chronic conditions.
Clinisupplies and Great Bear Healthcare are both growing organisations predominately focused on the UK healthcare market for continence products. The two companies provide continence care nursing services to support the NHS and offer a dedicated home delivery service for continence care products to patients’ homes.
Great Bear Healthcare is the first acquisition since Clinisupplies became a KKR portfolio company in January 2023 and is allied to the ambition of building an international chronic care medical devices platform.
Paul Cook, CEO of Clinisupplies, commented: “Becoming part of the KKR network and leveraging their team’s expertise helps us to support more consumers and engage with more healthcare professionals. Great Bear is the perfect fit for Clinisupplies to strengthen our core business in the UK and create a platform for future growth. We look very much forward to working with the Great Bear team and continuing the great work of founders who created a successful organisation.”
Al Hale, CEO of Great Bear, commented: “Clinisupplies is the right organisation to take Great Bear onto the next stage of its growth journey. The last 16 years has seen Great Bear grow from a new entrant to a strong player within the UK continence market. The investment which Clinisupplies is now able to bring to the organisation will enable further growth to support more patients across the UK.”
KKR invested in Clinisupplies through KKR Health Care Strategic Growth Fund II, a $4.0 billion fund focused on investing in high-growth healthcare companies. KKR has a long track record of supporting healthcare companies globally, having invested approximately $19 billion in the sector since 2004.
About Clinisupplies
Clinisupplies is a leading UK-based manufacturer and supplier of medical appliances specialising in continence products for managing acute and chronic conditions. Employing over 500 people in the UK, China and India, Clinisupplies supplies its products to the NHS and delivers direct to patients’ homes through Clinidirect, its dispensing appliance contractor.
Clinisupplies is focused on developing products which are simple and discreet to use. Its product development team works with clinicians and patients to develop a strong product pipeline to be manufactured at its CE, ISO, US FDA approved facilities.
Please visit www.clinisupplies.co.uk for further information.
About Great Bear
Great Bear Healthcare is a UK-based manufacturer and supplier of continence care products and operates the home delivery service Nightingale. The company was created in 2007 with the aim of developing a high-quality range of continence products to enable people to live the life they want to lead.
Great Bear has grown consistently and today employs more than 120 people working across Great Bear & Nightingale home delivery service. Great Bear is headquartered in Cardiff with home delivery services based in Cardiff & Bridgwater.
Please visit www.greatbearhealthcare.co.uk for further information.
About KKR
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com and on Twitter @KKR_Co.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230711298450/en/
Contact information
FGS Global
Alastair Elwen / Sophia Johnston
Telephone: +44 20 7251 3801
Email: KKR-Lon@FGSGlobal.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alipay+ Partners with Global Brands in #MoneyCannotBuy Initiative to Attract E-Wallet Users across Asia29.9.2023 04:43:00 EEST | Press release
Alipay+ today launches the #MoneyCannotBuy marketing initiative, a series of social media campaigns and special rewards, as the provider of cross-border digital payments and marketing solutions teams with global merchants in bringing a unique travel experience to Asia’s e-wallet users. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230928554669/en/ With the debut treat unveiled in Dubai, a group of lucky e-wallet users would win round-trip flights in Dubai to find out the poems they submitted through an earlier Alipay+ social media campaign are projected onto the Burj Khalifa to light up the sky. (Photo: Business Wire) #MoneyCannotBuy features major social media campaigns and special promotion from over 100 brands worldwide ranging from major theme parks to shopping malls, luxury retailers and major airports, for mobile-savvy travelers. In China and beyond, travelers are seeking more memorable and unique travel experiences o
Esri Launches Online GIS Course for Climate Action28.9.2023 23:01:00 EEST | Press release
As the impacts of climate change increase and intensify around the world, one aspect that has become clear is the geographic nature of the issue. The ability to tackle such a wide-reaching geographic challenge requires technology that gives context, which location intelligence provides. To support the individuals working toward this goal, Esri, the global leader in geographic information system (GIS) technology, today announced it will offer a new massive open online course (MOOC) exploring the application of its software to address climate change impacts. The complimentary course will be available this fall for six weeks on the Esri Academy website and includes full access to ArcGIS Pro, ArcGIS Network Analyst, ArcGIS Online, and other ArcGIS software that uses science-based tools and authoritative data. GIS for Climate Action opens on October 25 and provides a comprehensive introduction to how GIS software is used to ingest, map, visualize, analyze, and share massive amounts of data.
Bartek Ingredients on Track with New Facility Doubling Capacity and Cutting Emissions by 80 Percent28.9.2023 22:43:00 EEST | Press release
Bartek Ingredients is pleased to provide an update on its progress on the world’s largest malic and fumaric acid manufacturing facility. The project, which broke ground in January 2023, is on schedule to deliver product to customers by the end of September 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230928870100/en/ New Bartek manufacturing facility on track to deliver product by September 2024. (Photo: Business Wire) “We’re proud to confirm that we’re progressing as expected,” Bartek CEO John Burrows said. “We’re really excited to deliver our expanded capacity by next summer, in addition to new capabilities for a variety of new products.” Bartek expects the new facility to set a new global benchmark for plant safety, efficiency, and environmental performance. Among its anticipated accomplishments is a doubling of Bartek’s production capacity and a per unit greenhouse gas emissions reduction of more than 80 percent.
Brenus Pharma unveils promising pre-clinical results extrapolating human conditions in major international congresses.28.9.2023 17:30:00 EEST | Press release
Brenus Pharma announces that pre-clinical advancements of its inaugural research program were presented at the 7th CICON (International Cancer Immunotherapy) Conference in Milan, Italy (September 20-23) and will be showcased at the 38th Annual SITC (Society for Immunotherapy of Cancer) Congress in San Diego, CA, USA (November 1-5) These communications focus on pre-clinical validation of new developments of the first product generated by the STC Platform, STC-1010, which targets colorectal cancer in a first line of treatment. CONFERENCE TITLE AUTHORS RESULTS CICON23 P119: Allogenic Tumor Cell-Based Vaccine to Treat Colorectal Cancer: Development and Preclinical Validation George ALZEEB, Scientific Project Manager, Brenus Pharma, (Ph.D) Corinne TORTORELLI, Medical Lead, Brenus Pharma, (Pharm. D., Ph.D) Corentin RICHARD, Postdoc, Centre Georges-François Leclerc, ICMUB UMR CNRS 6302, (PhD) Romain BOIDOT, Molecular biologist, Centre Georges-François Leclerc, ICMUB UMR CNRS 6302, (PhD) Tangu
BM3EAC Corp. 2023 Semi-Annual Report28.9.2023 16:15:00 EEST | Press release
BM3EAC Corp. (the “Company”), a special purpose acquisition company incorporated under the laws of the Cayman Islands as an exempted company with limited liability and listed on Euronext Amsterdam, the regulated market operated by Euronext Amsterdam N.V., today published its semi-annual report for the period 1 January 2023 to 30 June 2023. The semi-annual report can be downloaded from the Company’s website via the following link: https://www.BrigadeM3EAC.com/documents IMPORTANT INFORMATION This press release contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. DISCLAIMER This announcement is not for distribution or release, directly or indirectly, and should not be distributed in or sent into, the United States, Australia, Canada, Japan, the Cayman Islands or South Africa or any other jurisdiction in which such distribution or release would be unlawful or would require registration or other measures. This announ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom